已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

3‐Month Melatonin Supplementation to Reduce Brain Oxidative Stress and Improve Sleep in Mild Cognitive Impairment: A Randomised Controlled Feasibility Trial

褪黑素 耐受性 医学 心情 安慰剂 随机对照试验 临床试验 痴呆 物理疗法 不利影响 内科学 精神科 替代医学 疾病 病理
作者
Zoe Menczel Schrire,Craig L. Phillips,Shantel L. Duffy,Nathaniel S. Marshall,Loren Mowszowski,Haley M La Monica,Lachlan Stranks,Christopher J. Gordon,Julia L. Chapman,Bandana Saini,Sharon L. Naismith,Ronald R. Grunstein,Camilla M. Hoyos
出处
期刊:Journal of Pineal Research [Wiley]
卷期号:76 (8): e70019-e70019 被引量:6
标识
DOI:10.1111/jpi.70019
摘要

ABSTRACT Melatonin has multiple proposed therapeutic benefits including antioxidant properties, circadian rhythm synchronisation and sleep promotion. Since these areas are also recognised risk factors for dementia, melatonin has been hypothesised to slow cognitive decline in older adults. Participants with Mild Cognitive Impairment (MCI) were recruited from the community for a 12‐week randomised placebo‐controlled parallel, feasibility trial of 25 mg oral melatonin nightly. Primary outcomes were feasibility, acceptability, and tolerability. Secondary efficacy outcomes were brain oxidative stress, cognition, mood, and sleep at 12 weeks. Forty participants (mean [SD] age = 68.2 [4.7] years; 19 female) were randomised. Feasibility, defined as those who met eligibility criteria, was 42/389, 11%. Acceptability, determined by the proportion of eligible people who agreed to be randomised, was 40/44, 91%. Tolerability, determined by adherence to the nightly melatonin and completion of the main secondary outcome (Magnetic Resonance Spectroscopy scan) was over the pre‐defined 80% threshold for all participants. The study was not powered to detect effectiveness. Accordingly, there were no significant differences between melatonin and placebo interventions in any of the secondary outcomes. The protocol was developed, and successfully implemented, with the planned number of eligible participants recruited. All participants were able to complete all aspects of the trial, including online visits and assessments, with no differences in adverse events between groups. This is promising for future trials, which should conduct the study with a larger sample size and longer duration to yield necessary efficacy data.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
Orange的应助被忧郁的恶天采纳,获得10
3秒前
keep发布了新的文献求助10
4秒前
4秒前
5秒前
maho完成签到,获得积分10
6秒前
ZMQ完成签到,获得积分10
7秒前
7秒前
8秒前
充电宝的应助被石永怡采纳,获得10
9秒前
单薄惜天发布了新的文献求助10
9秒前
9秒前
独特的龙猫完成签到,获得积分10
10秒前
酷波er的应助被留胡子的飞鸟采纳,获得10
12秒前
AUKO星星发布了新的文献求助10
14秒前
2026221709发布了新的文献求助10
14秒前
15秒前
george发布了新的文献求助10
17秒前
JamesPei的应助被南歪歪采纳,获得10
17秒前
H梦完成签到 ,获得积分10
18秒前
斯文败类的应助被俏皮以旋采纳,获得10
18秒前
18秒前
ZZC发布了新的文献求助10
20秒前
22秒前
24秒前
24秒前
sci完成签到,获得积分10
24秒前
ccc完成签到 ,获得积分10
27秒前
科研通AI6.4的应助被西红柿采纳,获得10
27秒前
gp发布了新的文献求助10
27秒前
28秒前
蒋心成发布了新的文献求助20
29秒前
25完成签到,获得积分10
29秒前
顺心的梦容完成签到,获得积分10
30秒前
石永怡发布了新的文献求助10
30秒前
31秒前
ZZC完成签到,获得积分10
31秒前
31秒前
33秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184619
求助须知:如何正确求助?哪些是违规求助? 9573576
关于积分的说明 21832380
捐赠科研通 7781845
什么是DOI,文献DOI怎么找? 3434399
关于科研通互助平台的介绍 2558498
邀请新用户注册赠送积分活动 2481003